Academic Journal

Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial

التفاصيل البيبلوغرافية
العنوان: Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial
المؤلفون: Koren, Michael A, Lin, Leyi, Eckels, Kenneth H, De La Barrera, Rafael, Dussupt, Vincent, Donofrio, Gina, Sondergaard, Erica L, Mills, Kristin T, Robb, Merlin L, Lee, Christine, Adedeji, Oluwaseun, Keiser, Paul B, Curley, Justin M, Copeland, Nathanial K, Crowell, Trevor A, Hutter, Jack N, Hamer, Melinda J, Valencia-Ruiz, Anais, Darden, Janice, Peel, Sheila, Amare, Mihret F, Mebrahtu, Tsedal, Costanzo, Margaret, Krebs, Shelly J, Gromowski, Gregory D, Jarman, Richard G, Thomas, Stephen J, Michael, Nelson L, Modjarrad, Kayvon
المصدر: The Lancet Infectious Diseases ; volume 23, issue 10, page 1175-1185 ; ISSN 1473-3099
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s1473-3099(23)00192-5
الاتاحة: http://dx.doi.org/10.1016/s1473-3099(23)00192-5
https://api.elsevier.com/content/article/PII:S1473309923001925?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1473309923001925?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; https://doi.org/10.15223/policy-017 ; https://doi.org/10.15223/policy-037 ; https://doi.org/10.15223/policy-012 ; https://doi.org/10.15223/policy-029 ; https://doi.org/10.15223/policy-004
رقم الانضمام: edsbas.E581016F
قاعدة البيانات: BASE
الوصف
DOI:10.1016/s1473-3099(23)00192-5